SEARCH
From NTUH pathologists to the Snapdragon Compute Ecosystem Summit, Dr. Eason Lin champions NextGen Digital Cytology.
Wellgen Medical Founder & CEO Dr. Eason Lin gave back-to-back talks advocating for the early detection of metastatic cancer through NextGen Digital Cytology, engaging both clinical and technology communities in a single week.
Dr. Lin first spoke at the Department of Pathology, National Taiwan University Hospital (NTUH), presenting to a group of cytopathologists on how NextGen Digital Cytology can improve the detection sensitivity of metastatic cancer, directly addressing a critical need in clinical diagnostics.
Dr. Lin later attended the 2025 Snapdragon Compute Ecosystem Summit, speaking to a full room of ecosystem partners about Digital Cytology and how Qualcomm's NPU technology helps improve AI inference time and energy performance—bridging the gap between clinical application and hardware innovation.
Wellgen Medical remains committed to innovation, made possible through the continued support of hospital users and ecosystem partners. These engagements reflect the company's ongoing efforts to advance its core mission of "AI-Assisted Diagnosis" across both clinical and technology communities.
依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「同意」即代表您同意採用目前的設定，更多資訊請瀏覽 隱私權聲明。
